Havas Group reports strong growth in its second quarter results

Posted on 29 July 2022

• The media company reported net revenue of $AUD936 million (€642 million)

Havas Group has posted continued growth in its second-quarter results ending June 30, 2022, under its parent company Vivendi.

The multinational media company reported a continued sustained level of activity in the second quarter and net revenue of $AUD936 million (€642 million).

The figure represents growth of 21.3% compared to the second quarter of 2021, and organic growth of 11.5%.

In the results of the first half of 2022, Havas Group’s revenues were $AUD1,831 million (€1,257 million), up by 19.9% compared to the first half of 2021.

Net revenues were $AUD1,757 million (€1,206 million) and the growth comprised of +11.5% in organic growth.

The Paris-based company noted that the “excellent” half-year operating performance was attributable to the robust commercial momentum built over recent quarters across all three divisions: Creative, Media and Health & Wellness.

According to the results, each region reported strong organic growth for the first half of 2022: Europe +11.7%, North America +7.6%, Asia Pacific +10.7%, and in Latin America +47.7%.

Acquisitions made a significant contribution during the first half of 2022 with majority interests in five targeted businesses aimed at bringing new skills on board and extending the group’s global presence.

This included: Tinkle (Spain and Portugal), Inviqa (United Kingdom and Germany), Search Laboratory (United Kingdom and United States), Frontier Australia (Australia) and Front Networks (China).

Havas also made special note of the main accounts won in the first half of 2022, including:

• Havas Creative: Back Market (Buzzman), Chewy (Arnold Boston), Department for Education (Havas London), Fiji Tourism (Havas Australia), Lincoln Financial (Havas New York), Journées Particulières LVMH (Havas Paris), SBK (Havas Germany), Shaze Luxury Retail (Havas India), TIM Telecom (Havas Italy), Yili (Havas China).
• Havas Health & You: Amgen, Guardant Health, LifeScan, Otsuka, Santhera, Albireo, UCB, Sanofi, Galderma,and Takeda.
• Havas Media: Boehringer Ingelheim (US), Klarna (US), Urovant (US), Claro (Peru), CoinSwitch (India), Europcar (Germany and France), Genesis (China), Matalan (UK), Optic 2000 (France), Pedidosya (LATAM).